Philip D. Davies, who serves as Vice President of Global Sales & Marketing at Vicor Corp (NASDAQ: VICR), completed a set of transactions on March 5, 2026 that included both the sale of outstanding shares and the exercise of company stock options.
On that date Davies sold 4,719 shares of Vicor common stock for aggregate proceeds of $1,027,828. The sales were executed under a pre-arranged Rule 10b5-1 trading plan and the shares changed hands at prices within a range of $177.18 to $202.1833 per share.
Also on March 5, Davies exercised options to acquire an additional 5,419 shares of Vicor common stock. The exercise prices for those options fell between $41.61 and $75.43 per share, and the total value associated with the option exercises amounted to $305,511. The awards exercised were identified as Non Qualified Stock Options.
The filings disclose the two components of activity - the disposition of existing shares under the Rule 10b5-1 arrangement and the contemporaneous conversion of option holdings into common stock through exercise. The report lists the precise share counts, price brackets, and aggregate dollar amounts for both the sales and the exercises.
No additional detail was provided in the transaction reporting about subsequent holdings, any re-sales of the newly acquired shares from the exercised options, or other contemporaneous trades by Davies. The documentation specifies the regulatory mechanism under which the sales were made but does not provide further explanation of the executive's broader equity strategy or cash management objectives.
Investors and market participants examining insider filings commonly note both the dollar scale of a sale and whether trades were carried out under a pre-established plan. In this case, the disposition of 4,719 shares generated roughly $1.03 million in proceeds, while the exercise of 5,419 options required approximately $305,511 in aggregate consideration based on the exercise prices reported.
Transaction details - at a glance
- Sale: 4,719 shares of common stock; proceeds $1,027,828; price range $177.18 to $202.1833.
- Options exercised: 5,419 shares; exercise price range $41.61 to $75.43; total exercise value $305,511.
- Sales executed under a pre-arranged Rule 10b5-1 trading plan; exercised awards were Non Qualified Stock Options.